Published on 12 Dec 2022 on Bloomberg via Yahoo Finance
Clovis Plans to Sell Cancer Drug to Novartis in Bankruptcy Deal
(Bloomberg) -- Clovis Oncology Inc. filed for bankruptcy and plans to sell its experimental cancer drug at an auction with Novartis Innovative Therapies making a binding, opening bid worth as much as $681 million.
Most Read from Bloomberg
China’s Rapid Covid Reversal Sparks Whiplash as Cases SurgeUS Says Scientists Make Breakthrough in Nuclear Fusion EnergyElon Musk Is Ruining Trump’s Presidential CampaignUS Stocks Start Fed Week Higher as CPI Data Loom: Markets WrapFed’s Message That Rates Will Stay on Hold for ‘Some Time’ Clashes With 2023 Rate-Cut Bets